In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. (Q42181792)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. |
scientific article |
Statements
1 reference
In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122. (English)
1 reference
Søren Ottosen
1 reference
Todd B Parsley
1 reference
Lu Yang
1 reference
Karin Zeh
1 reference
Leen-Jan van Doorn
1 reference
Eva van der Veer
1 reference
Anneke K Raney
1 reference
Michael R Hodges
1 reference
Amy K Patick
1 reference
10 November 2014
1 reference
1 reference
Identifiers
1 reference